The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Engelson Erik T. since 2022.
This trader's CIK number is 1839384.
At the time of last reporting, Engelson Erik T. was the President and Chief Executive of Lucira Health, Inc.. (stock ticker symbol LHDX).
Also see all insider trading activities at Lucira Health, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | LHDX | 0 | $0 | 634,666 | $672,745 | 574,666 | $471,226 |
2022 | LHDX | 60,000 | $141,300 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-03-03 | LHDX | Sale | 634,666 | 1.06 | 672,745 |
2023-03-03 | LHDX | Option Ex | 574,666 | .82 | 471,226 |
2022-09-15 | LHDX | Buy | 20,000 | 1.82 | 36,400 |
2022-06-16 | LHDX | Buy | 10,000 | 1.49 | 14,900 |
2022-03-15 | LHDX | Buy | 30,000 | 3.00 | 90,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Engelson Erik T. (President and Chief Executive of Lucira Health, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.